Pathophysiology, Genetics & Classification

Question	Answer
1. What is the fundamental molecular trigger responsible for initiating the immunopathogenesis of Rheumatic Fever?	Infection by Group A Streptococcus (Streptococcus pyogenes), specifically pharyngeal infections caused by rheumatogenic strains expressing M-protein.
2. Explain the immunological concept of molecular mimicry in Rheumatic Heart Disease.	1. Streptococcal M-protein shares structural and antigenic epitopes with human host structural proteins like myosin, laminin, and vimentin. 2. Antibodies and T-cells raised against streptococcal antigens cross-react with myocardial and valvular tissues, triggering autoimmune injury.
3. Which class of human leukocyte antigens (HLA) has been consistently implicated in genetic susceptibility to Rheumatic Fever and RHD?	Specific HLA class II alleles, notably HLA-DR7 and HLA-DR4, show significant genetic association with increased host susceptibility to rheumatic carditis.
4. What is the pathognomonic histological lesion of acute rheumatic carditis, and what are its constituent cellular elements?	1. The Aschoff body. 2. It consists of a central zone of fibrinoid necrosis surrounded by T-lymphocytes, plasma cells, and pathognomonic Anitschkow cells (caterpillar cells) along with modified macrophages (Aschoff giant cells).
5. What is an Anitschkow cell, and why is it considered characteristic of rheumatic carditis?	An Anitschkow cell is a specialized activated macrophage with abundant cytoplasm and a central, condensed block of chromatin forming a wavy, caterpillar-like ribbon; it is virtually pathognomonic for rheumatic tissue reactions.
6. Which anatomical layers of the heart are involved in acute rheumatic carditis, justifying the term pancarditis?	Pancarditis involves the endocardium (manifesting as valvulitis), the myocardium (manifesting as Aschoff bodies in the interstitial tissue), and the pericardium (manifesting as a fibrinous serofibrinous pericarditis).
7. Which cardiac valve is most frequently and severely affected in Rheumatic Heart Disease?	The mitral valve is affected in almost 100% of cases of chronic RHD, followed closely in frequency by the aortic valve, while tricuspid and pulmonary valves are rarely involved in isolation.
8. VIVA TRAP: Can isolated acute rheumatic involvement of the pulmonary valve occur without left-sided valvular lesions?	NONE. Isolated pulmonary valve involvement in rheumatic heart disease is virtually nonexistent; right-sided lesions almost invariably occur secondary to severe left-sided heart disease and elevated pulmonary pressures.
9. What is the primary cellular mechanism leading to permanent valve leaflet thickening and commissural fusion in chronic RHD?	Chronic, recurrent immune-mediated inflammation leads to neovascularization, fibroblastic proliferation, collagen deposition, and subsequent scarring, leaflet retraction, and commissural fusion.
10. How does MacCallum's patch contribute to the macroscopic pathology seen in acute rheumatic carditis?	MacCallum's patch represents an irregular, thickened, subendothelial plaque of fibrous tissue located on the posterior wall of the left atrium, caused by the regurgitant jet streaming against the atrial endocardium.
11. What is the currently accepted international standard classification system for grading latent and clinical RHD on echocardiography?	The 2012 World Heart Federation (WHF) echocardiographic criteria, which categorize findings into Definite RHD, Borderline RHD, and Normal variants based on specific morphological and spectral Doppler criteria.
12. According to WHF criteria, what are the primary morphological features of rheumatic mitral valve disease seen on 2D echo?	1. Excessive leaflet tip thickening. 2. Chordal thickening and fusion. 3. Restricted leaflet motion (doming of the anterior mitral leaflet).
13. Differentiate between pathological mitral regurgitation (MR) and physiological MR under the WHF echocardiographic criteria for borderline RHD.	Pathological MR must be seen in at least two views, jet length must be at least 2 cm, velocity must be high throughout systole (pansystolic), and it must originate from a regurgitant orifice rather than being a benign trace/physiological leak.
14. What are the key pathophysiological consequences of chronic mitral stenosis resulting from healed RHD?	1. Progressive left atrial pressure overload and dilation. 2. Pulmonary venous hypertension leading to pulmonary arterial hypertension. 3. Eventual right ventricular hypertrophy and right heart failure.
15. Why is chorea (Sydenham chorea) considered a delayed neurological manifestation of acute rheumatic fever involving the central nervous system?	It is caused by molecular mimicry where anti-basal ganglia antibodies cross-react with neuronal antigens in the caudate nucleus and putamen of the brain.
16. What is the pathophysiological role of transforming growth factor-beta (TGF-beta) in the progression of chronic rheumatic valve disease?	TGF-beta acts as a potent profibrotic cytokine that drives myofibroblast differentiation and excessive extracellular matrix accumulation, perpetuating progressive valve fibrosis and stiffening even after streptococcal clearance.
17. VIVA TRAP: Does a negative throat culture for Group A Streptococcus definitively rule out acute rheumatic fever?	NO. By the time acute rheumatic fever and carditis clinically manifest weeks after the initial pharyngitis, the streptococcal infection has usually cleared from the pharynx, resulting in negative throat cultures; diagnosis relies on elevated or rising anti-streptolysin O (ASO) or anti-DNase B titers.
18. What is the genetic basis for differing host immune responses to Group A Streptococcal antigens in RHD pathogenesis?	Polygenic inheritance involving genes encoding cytokines (e.g., TNF-alpha, TGF-beta, IL-10), mannose-binding lectin, and specific T-cell receptor variants that modulate the magnitude of autoimmune inflammation.
19. What anatomical and hemodynamic factors predispose the mitral valve to bear the brunt of rheumatic valvulitis?	The mitral valve experiences the highest mechanical and hemodynamic stress within the high-pressure left-sided circulation, facilitating localized microtrauma that localizes circulating cross-reactive immune complexes and inflammatory cells.

Clinical History & Bedside Evaluation

Question	Answer
1. What is the classic peak age distribution for the initial presentation of Acute Rheumatic Fever and subsequent Rheumatic Heart Disease in pediatric practice?	1. ARF predominantly affects children aged 5 to 15 years. 2. It is exceptionally rare in children under 3 years of age due to the time required for repeated streptococcal exposures and immune maturation.
2. How does the chronological progression from untreated streptococcal pharyngitis to the clinical onset of carditis typically manifest in history?	1. There is a classic latent period of 2 to 4 weeks (shorter for arthritis, longer for chorea) following an episode of acute pharyngitis. 2. A history of preceding sore throat is frequently mild or forgotten in up to one-third of pediatric cases in developing settings.
3. What specific socio-environmental risk factors must be actively elicited during the dietary and housing history of a suspected RHD patient?	1. Overcrowding, poor housing ventilation, and low socioeconomic status are the major predisposing environmental risk factors. 2. These conditions facilitate the rapid droplet transmission of Group A Beta-Hemolytic Streptococcus within families and schools.
4. What are the key elements of the perinatal and early developmental history that must be documented, and how do they impact the differential diagnosis?	1. A normal perinatal and early developmental history is typical in RHD, sharply contrasting with congenital heart diseases where failure to thrive and early cyanosis or heart failure present in infancy. 2. Documenting this helps rule out congenital shunts or cardiomyopathies presenting in older children.
5. How should a family pedigree be structured when evaluating a pediatric patient with suspected rheumatic fever or carditis?	1. The pedigree must screen for a history of recurrent sore throats, rheumatic fever, childhood chorea, early-onset valve replacements, or premature death from heart failure among first-degree relatives. 2. A positive family history strongly points toward shared environmental exposure and potential genetic susceptibility markers.
6. What are the primary differential diagnostic red flags in the clinical history that should make an examiner suspect a cause other than RHD for acute carditis?	1. The presence of high-grade persistent fever beyond 3 weeks, embolic phenomena, or unresponsiveness to salicylates/steroids points toward Infective Endocarditis. 2. Onset in infancy or neonatal age strongly suggests congenital heart disease rather than acquired RHD.
7. How do the presenting symptoms of isolated mitral regurgitation differ chronologically from those of established mitral stenosis in pediatric RHD?	1. Acute rheumatic carditis typically presents with progressive exertional fatigue, palpitations, and breathlessness due to acute or subacute mitral regurgitation. 2. Mitral stenosis develops silently over years, presenting later in adolescence with exertional dyspnea, orthopnea, or hemoptysis.
8. VIVA TRAP: Can a precise history of a clinically apparent sore throat be elicited in every pediatric patient presenting with acute rheumatic fever?	NEVER. Up to 30 to 50 percent of patients or their caregivers report no preceding history of pharyngitis, as the primary streptococcal infection was subclinical or completely asymptomatic.
9. What specific joint history distinguishes the migratory polyarthritis of acute rheumatic fever from other pediatric arthritides?	1. The arthritis classically involves large joints (knees, ankles, wrists, elbows) in a rapidly migratory fashion, where inflammation jumps from one joint to another over days. 2. Each individual joint swelling resolves completely within 1 to 2 weeks without permanent deformity, and it exhibits a dramatic response to aspirin.
10. How does the history of neurological complaints in Sydenham chorea present, and what is its typical timeline relative to other ARF manifestations?	1. Parents report insidious onset of purposeless, involuntary, non-rhythmic movements of the limbs and face, emotional lability, and deterioration in handwriting. 2. Chorea has a long latency period (up to 1 to 6 months post-strep infection) and may appear as an isolated manifestation long after arthritis and fever have resolved.
11. What cutaneous history or bedside observation should a clinician specifically inquire about or look for when suspecting acute rheumatic carditis?	1. Inquire about transient, non-pruritic, pink rashes with central clearing known as Erythema Marginatum, predominantly over the trunk and proximal extremities. 2. Also palpate for painless, small subcutaneous nodules over bony prominences such as the extensor tendons of the wrists and elbows.
12. How does the functional class assessment (NYHA or modified Ross scale) dictate the bedside evaluation of exercise tolerance in a child with chronic RHD?	1. The clinician must quantify daily activities, such as how many flights of stairs the child can climb or school attendance limitations. 2. Progressive limitation from Class I to Class IV indicates worsening hemodynamic compromise and remodeling of the rheumatic valves.
13. What bedside physical signs during general examination indicate chronic severe mitral regurgitation in an older pediatric patient with RHD?	1. Inspection reveals a hyperactive apex beat displaced laterally and inferiorly. 2. Palpation demonstrates a left ventricular heave and a hyperdynamic apex, often accompanied by a left parasternal lift if pulmonary hypertension has supervened.
14. How should the clinical examiner differentiate the apical holosystolic murmur of rheumatic mitral regurgitation from the murmur of a ventricular septal defect at the bedside?	1. Rheumatic MR murmur is a high-pitched, blowing holosystolic murmur best heard at the apex that radiates to the left axilla and is accompanied by a soft S1 or third heart sound. 2. VSD murmurs are typically harsh, pansystolic, loudest at the left lower sternal border, and often associated with a palpable thrill.
15. What bedside auscultatory maneuvers are essential when evaluating a patient suspected of having rheumatic mitral stenosis?	1. Auscultation using the bell of the stethoscope strictly at the localized apex in the left lateral decubitus position. 2. Listening specifically for a loud first heart sound (S1), an opening snap following S2, and a low-pitched, rumbling mid-diastolic murmur with presystolic accentuation in sinus rhythm.
16. VIVA TRAP: Is the presence of a soft, early systolic murmur at the apex in a febrile child sufficient to diagnose acute rheumatic carditis at the bedside?	NO. Innocent functional murmurs are extremely common in febrile children; a pathological rheumatic murmur must meet specific auscultatory criteria (duration > or = to seconds, high pitch, holosystolic or early/mid-diastolic) or be confirmed by echocardiography.
17. What bedside physical findings suggest the development of pulmonary hypertension secondary to long-standing mitral valve disease in RHD?	1. A palpable and loud pulmonic component of the second heart sound (P2) out-of-proportion to aortic component (A2). 2. A parasternal heave reflecting right ventricular hypertrophy, and occasionally the early diastolic decrescendo murmur of pulmonary regurgitation (Graham Steell murmur).
18. How does the nutritional and anthropometric history aid in evaluating the severity of chronic rheumatic heart disease in a pediatric patient?	1. Chronic severe RHD with persistent heart failure leads to cardiac cachexia, growth failure, and stunting due to chronic hypoxia, increased metabolic demand, and poor caloric intake. 2. Documenting serial height and weight centiles helps grade the chronicity and hemodynamic burden of the valvular lesion.
19. What specific historical inquiry must be made regarding prior medication compliance in a known case of RHD presenting with acute decompensation?	1. Detailed recall of adherence to secondary antibiotic prophylaxis, specifically intramuscular Benzathine Penicillin G every 3 to 4 weeks. 2. Non-compliance is the single most common historical factor leading to recurrent streptococcal infections, recurrent carditis, and progressive valve destruction.

Physical Examination & Bedside Signs

Question	Answer
1. How does anthropometric assessment using Indian Academy of Pediatrics (IAP) growth charts assist in evaluating a pediatric patient with chronic severe Rheumatic Heart Disease?	Chronic severe RHD with heart failure often leads to cardiac cachexia and protein-energy malnutrition. Serial anthropometry helps assess the chronicity of hemodynamic compromise, guides nutritional rehabilitation, and dictates dosing regimens for heart failure medications.
2. What specific inspection findings in the general physical examination point toward chronic left ventricular volume overload in severe rheumatic mitral regurgitation?	Inspection reveals prominent, hyperdynamic apex beat displaced inferiorly and laterally, along with visible suprasternal and intercostal pulsations indicating cardiomegaly and increased stroke volume.
3. How is the apical impulse palpated to differentiate volume overload from pressure overload in rheumatic heart disease?	Volume overload (such as in mitral or aortic regurgitation) produces a diffuse, hyperdynamic, down-and-out apex beat with a brisk tapping quality. Pressure overload (such as in mitral stenosis or pulmonary hypertension) produces a sustained, heaving, localized apex beat.
4. What bedside palpation technique is used to detect a diastolic thrill, and where is it optimally felt in pure rheumatic mitral stenosis?	The examiner uses the flat of the palm or ulnar aspect of the hand over the apex beat with the patient in the left lateral decubitus position, specifically during end-expiration, to feel the localized low-frequency rumbling thrill.
5. How do you elicit a parasternal heave, and what does its presence indicate in a patient with chronic RHD?	A parasternal heave is felt by placing the heel of the right hand firmly along the left sternal edge; a sustained upward lift indicates right ventricular hypertrophy secondary to pulmonary hypertension caused by long-standing mitral stenosis.
6. What is the precise auscultatory characteristic and mechanism of the First Heart Sound (S1) in early rheumatic mitral stenosis with pliable valves versus calcific late disease?	In early rheumatic mitral stenosis with pliable valve leaflets, S1 is loud and snapping because the high left atrial pressure keeps the valve wide open until late, requiring forceful closure. In calcific, immobile leaflets, S1 becomes soft or absent.
7. How do you optimally auscultate the Opening Snap (OS) of mitral stenosis, and what does the A2-OS interval signify?	The OS is best heard with the diaphragm of the stethoscope just medial to the apex in the left lateral position. A shorter A2-OS interval indicates higher left atrial pressure and more severe mitral stenosis.
8. Describe the classic auscultatory features of the middiastolic murmur (MDM) with presystolic accentuation in rheumatic mitral stenosis.	The MDM is a low-pitched, rumbling murmur heard exclusively with the bell of the stethoscope at the apex in the left lateral position. Presystolic accentuation occurs due to active atrial contraction driving blood across the stenotic valve just before ventricular systole, provided the rhythm is in sinus rhythm.
9. What bedside auscultatory maneuver is mandatory when listening for the early diastolic decrescendo murmur of aortic regurgitation associated with RHD?	The examiner must apply the diaphragm of the stethoscope firmly along the left sternal border (third and fourth intercostal spaces), with the patient sitting up, leaning forward, and holding breath in deep expiration.
10. What bedside physical sign is elicited by examining the subclavicular or apical regions for an Austin Flint murmur?	The Austin Flint murmur is a functional mid-diastolic or presystolic rumble heard at the apex caused by the severe aortic regurgitant jet fluttering the anterior mitral leaflet; it differs from mitral stenosis by lacking an opening snap and a loud S1.
11. What inspection findings in the hands and nails suggest infective endocarditis superimposed on a pre-existing rheumatic heart valve lesion?	Clinician should actively inspect for splinter hemorrhages, Osler nodes on the pulp of fingers, Janeway lesions on palms, and clubbing, which indicate subacute bacterial endocarditis complicating RHD.
12. How do you examine for peripheral signs of a hyperdynamic circulation characteristic of chronic severe aortic regurgitation in RHD?	Check for a wide pulse pressure resulting in water-hammer pulse, Quincke capillary pulsations in nail beds, de Musset sign (head nodding with each pulse), and Corrigan pulse upon palpation of carotid arteries.
13. What specific neurological bedside signs are elicited to confirm the diagnosis of Sydenham chorea in an active rheumatic fever presentation?	Test for milkmaid's sign (inability to maintain a steady grip), pronator sign (turning palms outward when arms are held overhead), spooning of hands, and irregular, purposeless, involuntary movements exacerbated by stress and absent during sleep.
14. How is the bedside test for hepatojugular reflux performed, and what does a positive response signify in rheumatic heart failure?	Firm pressure is applied over the right upper quadrant/liver for 10 to 15 seconds while observing the internal jugular vein; a sustained rise in jugular venous pressure greater than 3 cm indicates right ventricular failure secondary to RHD.
15. What physical sign is elicited by palpating the liver in a child with severe tricuspid regurgitation secondary to long-standing RHD?	Palpation reveals a tender, enlarged liver that exhibits systolic pulsations (expansile hepatic pulsation), which distinguishes it from transmitted aortic pulsations.
16. How do you assess jugular venous pressure (JVP) waveform abnormalities at the bedside in a patient with rheumatic tricuspid stenosis or regurgitation?	In tricuspid stenosis, look for a prominent 'a' wave in sinus rhythm; in tricuspid regurgitation, look for a prominent systolic 'v' wave and loss of the 'x' descent with a rapid 'y' descent.

Diagnostic Criteria & Investigations

Question	Answer
1. What are the major and minor manifestations included in the 2015 World Health Organization (WHO) revision of the Jones criteria for diagnosing Acute Rheumatic Fever in low-risk versus moderate-to-high risk populations?	1. Major criteria include carditis, polyarthritis, chorea, erythema marginatum, and subcutaneous nodules (with monoarthritis or polyarthralgia and fever added for moderate-to-high risk populations). 2. Minor criteria include clinical findings of polyarthralgia (in low-risk) or monoarthralgia/polyarthritis (in moderate-to-high), fever (≥38.5 °C), elevated acute phase reactants (ESR ≥30 mm/hr or CRP ≥3.0 mg/dL), and prolonged PR interval on ECG.
2. What are the specific ECG criteria and cutoffs for defining a prolonged PR interval adjusted for age and heart rate in a suspected case of Acute Rheumatic Fever?	1. A prolonged PR interval represents first-degree heart block, a frequent minor manifestation of ARF. 2. Cutoffs vary by age and heart rate, but generally, a PR interval greater than 0.16 seconds in children aged 6–12 years or greater than 0.18 seconds in adolescents is considered abnormal and supportive of carditis.
3. What are the echocardiographic and Doppler criteria required to diagnose definite subclinical or clinical rheumatic carditis according to current guidelines?	1. Pathological mitral regurgitation seen in at least two views (jet length ≥2 cm, pansystolic, high velocity >3 m/s, and directed posteriorly into the left atrium). 2. Pathological aortic regurgitation seen in at least two views (jet length ≥1 cm, holodiastolic, high velocity >3 m/s). 3. Morphological changes of RHD such as leaflet thickening, restricted motion, and chordal elongation.
4. What are the precise laboratory cutoffs for erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) that fulfill the acute-phase reactant minor criteria in the Jones criteria?	1. ESR must be ≥30 mm in the first hour by Westergren method. 2. CRP must be ≥3.0 mg/dL (or 30 mg/L). 3. Notably, CRP remains elevated strictly during acute inflammation and normalizes rapidly, whereas ESR can remain elevated longer.
5. What microbiological tests are considered acceptable evidence of a preceding group A streptococcal (GAS) infection for satisfying Jones criteria?	1. A positive throat culture for Streptococcus pyogenes. 2. A rapid antigen detection test (RADT) positive for GAS. 3. Elevated or rising streptococcal antibody titers, most notably anti-streptolysin O (ASO) titer (>200 Todd units in children) or anti-deoxyribonuclease B (anti-DNase B) titer.
6. What is the gold standard imaging modality for the definitive diagnosis and grading of structural valvular lesions in Rheumatic Heart Disease?	1. Transthoracic echocardiography (TTE) combined with Color Doppler is the gold standard. 2. It provides real-time visualization of leaflet morphology, chordal apparatus, valve area calculation via pressure half-time or planimetry, and quantification of regurgitant jets.
7. VIVA TRAP: Can a single elevated ASO titer in the absence of any other clinical or laboratory markers reliably confirm acute rheumatic fever?	NO. A single elevated ASO titer only proves a prior streptococcal infection, which is extremely common in healthy school-aged children in endemic areas; it does not confirm acute rheumatic fever without fulfilling the Jones criteria.
8. What specific blood biomarker, apart from acute phase reactants, is utilized to assess myocardial injury and heart failure severity in acute rheumatic carditis?	1. N-terminal pro-B-type natriuretic peptide (NT-proBNP) or plasma BNP. 2. Serum cardiac troponin I or T may also be elevated in severe pancarditis indicating myocardial inflammation or myocyte necrosis.
9. What ECG findings other than a prolonged PR interval may be observed during the acute phase of severe rheumatic carditis?	1. Sinus tachycardia out of proportion to fever. 2. ST-segment elevation or T-wave inversion reflecting associated epicarditis or myocarditis. 3. Low QRS voltages in limb leads due to myocardial edema or pericardial effusion.
10. What hematological abnormalities other than elevated ESR/CRP are typically found on complete blood count (CBC) during active acute rheumatic fever?	1. Polymorphonuclear leukocytosis. 2. Normocytic, normochromic anemia of chronic disease or inflammation.
11. What are the characteristic CT or MRI imaging findings when evaluating complex or atypical cases of RHD or associated pericardial involvement?	1. Cardiac magnetic resonance (CMR) imaging can precisely quantify ventricular volumes, ejection fraction, and characterize myocardial tissue inflammation or fibrosis using late gadolinium enhancement (LGE). 2. CT angiography is primarily reserved for evaluating coronary anatomy or pre-surgical vascular mapping when echocardiography is inconclusive.
12. What throat swab handling precaution is mandatory if a rapid antigen test is negative in a patient with suspected streptococcal pharyngitis triggering ARF?	1. A backup throat culture on sheep blood agar must be performed because rapid antigen tests have high specificity but lower sensitivity, and missing a GAS infection compromises diagnostic certainty for ARF.
13. VIVA TRAP: Are acute phase reactants (ESR and CRP) universally elevated in every patient presenting with a confirmed diagnosis of Sydenham chorea?	NO. Sydenham chorea is a delayed, isolated manifestation of ARF where the latent period can be up to 6 months; by the time chorea appears, acute phase reactants have often normalized and throat cultures or ASO titers may have returned to baseline.
14. How do you differentiate the carditis of acute rheumatic fever from Kawasaki disease coronary arteritis and myocarditis on initial cardiac evaluation?	1. Acute rheumatic carditis typically presents with pancarditis (valvulitis, myocarditis, pericarditis) characterized predominantly by regurgitant valvular lesions, whereas Kawasaki disease characteristically involves coronary artery aneurysms/dilatation and transient coronary microvascular dysfunction without primary chronic valvular destruction. 2. Rheumatic fever has a classic history of antecedent pharyngitis and positive streptococcal titers, unlike Kawasaki disease which presents with mucocutaneous lymph node syndrome features.
15. What specific leukocyte or cytokine profiles are currently investigated as potential adjunct biomarkers for acute rheumatic carditis activity?	1. Raised peripheral blood white cell counts with neutrophilia. 2. Elevated pro-inflammatory cytokines such as IL-1 beta, IL-6, and TNF-alpha, though these remain largely experimental and are not part of routine clinical diagnostic criteria.
16. What is the recommended duration and frequency of echocardiographic follow-up for a patient diagnosed with subclinical RHD detected via school screening programs?	1. Serial echocardiography every 6 to 12 months is recommended to monitor for progression of valvular lesions, resolution, or the development of clinical carditis. 2. Continuous secondary antibiotic prophylaxis with benzathine penicillin G must be initiated promptly upon confirmation of subclinical RHD.

Evidence-Based Management & Pharmacotherapy

Question	Answer
1. What is the standard antibiotic regimen and dosage for primary prophylaxis against Group A Streptococcus to prevent initial acute rheumatic fever?	1. Single intramuscular injection of Benzathine Penicillin G: 600,000 units for children ≤27 kg and 1.2 million units for children >27 kg. 2. Alternatively, oral Penicillin V 250 mg twice or three times daily for 10 days, or Erythromycin (20–40 mg/kg/day divided) for penicillin-allergic patients.
2. What is the recommended dosing schedule and route for secondary antibiotic prophylaxis using Benzathine Penicillin G in established Rheumatic Heart Disease?	1. Administer Benzathine Penicillin G 1.2 million units (0.6 million units if <27 kg) intramuscularly every 3 weeks strictly. 2. The 3-week interval is strongly recommended in endemic settings like India to maintain adequate minimum inhibitory concentrations compared to the 4-week international schedule.
3. What is the duration of secondary antibiotic prophylaxis for a patient with RHD who had carditis with residual heart valve disease?	Secondary prophylaxis must be continued for at least 10 years after the last episode or until 40 years of age, and often lifelong for patients with severe valve disease or those with high exposure risks (e.g., healthcare or school teachers).
4. What anti-inflammatory medication and initial dosage are indicated for a child presenting with Acute Rheumatic Fever with moderate to severe carditis and cardiomegaly?	1. Oral Prednisolone at 1 to 2 mg/kg/day (maximum 60 mg/day) divided into 2–3 doses for 2 to 3 weeks. 2. Tapering should be done gradually over 2 to 3 weeks while overlapping with aspirin to prevent rebound phenomena.
5. When is Aspirin preferred over Corticosteroids in managing Acute Rheumatic Fever, and what is the standard therapeutic dosage?	1. Aspirin is used when arthritis and/or mild fever are present without significant carditis. 2. The dosage is 80 to 100 mg/kg/day in divided doses (maximum 4–6 g/day) adjusted to maintain serum salicylate levels between 20 to 30 mg/dL.
6. What is the mechanism of action of Benzathine Penicillin G in preventing acute rheumatic fever, and why does penicillin resistance not pose a clinical problem here?	1. Penicillin inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), causing lysis of Streptococcus pyogenes. 2. Group A Streptococcus has maintained 100% susceptibility to penicillin without documented clinical resistance over decades.
7. How do you manage acute heart failure secondary to severe acute rheumatic carditis in the pediatric emergency setting?	1. Immediate fluid restriction, oxygen supplementation, and loop diuretics (Furosemide 1 mg/kg IV). 2. Afterload reduction using ACE inhibitors (e.g., Enalapril 0.1 mg/kg/day titrated) and inotropic support (Milrinone or Dobutamine) if myocardial dysfunction is profound.
8. What are the key baseline and periodic laboratory monitoring parameters required for a child receiving long-term high-dose Aspirin therapy for ARF?	1. Serum salicylate levels, liver function tests (AST/ALT), renal function tests, and complete blood counts with platelets. 2. Monitor closely for signs of salicylism (tinnitus, hyperventilation, vomiting) and occult GI bleeding.
9. What specific pharmacotherapy is indicated for managing disabling hyperkinesia and behavioral outbursts in severe Sydenham chorea?	1. Dopamine receptor blockers or modulators like Valproic acid (15–30 mg/kg/day), Carbamazepine (10–20 mg/kg/day), or Haloperidol (0.01–0.03 mg/kg/day). 2. Corticosteroids or IVIG are reserved for severe, refractory cases associated with active neuroinflammation.
10. What premedication or emergency preparedness is mandatory prior to administering intramuscular Benzathine Penicillin G in clinical practice?	1. Immediate availability of emergency resuscitation equipment and injectable Adrenaline (1:1000, dose 0.01 mg/kg up to 0.5 mg IM). 2. Patients must be observed in the clinic for at least 20 to 30 minutes post-injection to monitor for acute anaphylaxis.
11. What are the absolute class I surgical indications for intervention in a pediatric patient with chronic rheumatic mitral regurgitation?	1. Development of symptoms (NYHA Class III/IV heart failure). 2. Objective evidence of progressive left ventricular dysfunction (LVESD >40 mm or EF <60% by echocardiography) despite optimal medical management.
12. What are the specific indications for balloon mitral valvotomy (BMV) versus open/closed surgical commissurotomy in pediatric rheumatic mitral stenosis?	1. Percutaneous balloon mitral valvotomy is indicated for isolated, pliable, non-calcified mitral stenosis valves without significant regurgitation or left atrial thrombus. 2. Surgical commissurotomy or valve replacement is reserved for heavily calcified, severely deformed valves with subvalvular fusion or associated severe regurgitation.
13. What is the choice of valve prosthesis (mechanical versus bioprosthetic) in a growing child requiring surgical valve replacement for end-stage RHD?	1. Mechanical heart valves are generally preferred in children and adolescents due to superior long-term durability, despite the requirement for lifelong oral anticoagulation. 2. Bioprosthetic valves undergo rapid calcific degeneration in pediatric patients due to high calcium turnover.
14. What are the target therapeutic INR ranges and monitoring protocols for a pediatric patient with a mechanical mitral valve prosthesis for RHD?	1. Target INR range is typically 2.5 to 3.5 for mechanical mitral valves (or 2.0 to 3.0 depending on mechanical valve type and risk factors). 2. Monitor INR weekly during stabilization and at least every 3 to 4 weeks once stable, alongside education on dietary Vitamin K consistency.
15. What are the prophylactic antibiotic recommendations for infective endocarditis in a patient with RHD undergoing dental or surgical procedures?	1. Antibiotic prophylaxis is currently restricted to high-risk patients (those with prosthetic heart valves, prior IE, or unrepaired cyanotic congenital heart disease) undergoing high-risk dental procedures involving manipulation of gingival tissue or periapical region. 2. Standard regimen: Amoxicillin 50 mg/kg orally 30–60 minutes before the procedure.
16. What therapeutic agent is indicated for managing acute atrial fibrillation with rapid ventricular response in a child with severe rheumatic mitral stenosis?	1. Intravenous Beta-blockers (e.g., Metoprolol 0.1–0.2 mg/kg or Esmolol) or non-dihydropyridine calcium channel blockers (Verapamil/Diltiazem, avoided in decompensated HF) to slow ventricular rate. 2. Urgent synchronized direct-current cardioversion if hemodynamic instability is present.
17. VIVA TRAP: Can oral penicillin V be safely substituted for monthly Benzathine Penicillin G injections in secondary prophylaxis for compliance improvement in RHD?	NO. Oral penicillin V has significantly higher compliance failure rates and inferior recurrence prevention compared to supervised 3-weekly intramuscular Benzathine Penicillin G injections; thus, oral prophylaxis is discouraged unless IM access is refused.
18. What is the pharmacological management strategy for a patient who develops a steroid-resistant rebound of acute rheumatic carditis during dose tapering?	1. Temporarily increase the Prednisolone dose back to the initial therapeutic level until clinical and laboratory inflammatory markers normalize. 2. Introduce or optimize concomitant Aspirin therapy and taper steroids much more slowly over an extended period.
19. What long-term cardiovascular surveillance and imaging protocol must be maintained for an asymptomatic child with healed rheumatic carditis and trace MR?	1. Clinical evaluation and comprehensive echocardiographic assessment every 6 to 12 months. 2. Strict adherence to secondary antibiotic prophylaxis and continuous education regarding symptoms of heart failure and infective endocarditis.
20. What specific laboratory investigations and precautions are mandatory before initiating Warfarin anticoagulation therapy in a child post-valve replacement?	1. Baseline baseline PT/INR, aPTT, complete blood count, renal and liver function tests, and exclusion of bleeding diathesis or CNS pathology. 2. Patient and family counseling regarding avoidance of contact sports, recognition of bleeding signs, and consistent dietary Vitamin K intake.

High-Yield VIVA TRAPs & Examiner Pitfalls

Question	Answer
1. VIVA TRAP: Can secondary prophylaxis with Benzathine Penicillin G be completely stopped once a child with RHD reaches 18 years of age, regardless of residual valvular lesions?	NEVER. For patients with residual heart valve disease, secondary prophylaxis must be continued at least until 40 years of age or lifelong, as the risk of recurrent attacks causing cumulative valve damage persists well into adulthood.
2. VIVA TRAP: Is an isolated high anti-streptolysin O (ASO) titer sufficient evidence to diagnose an acute attack of rheumatic fever in a child presenting with arthralgia?	NO. An elevated ASO titer only indicates a recent Group A Streptococcal infection; it lacks specificity and must be correlated with clinical findings fulfilling the Jones criteria (e.g., carditis, chorea) to diagnose ARF.
3. VIVA TRAP: Should therapeutic doses of aspirin be continued indefinitely in a child who has recovered from acute rheumatic carditis without residual murmurs?	NO. Aspirin is used for a finite duration (typically 6 to 8 weeks with a slow taper) to suppress the acute inflammatory response of carditis, and is discontinued once inflammatory markers normalize.
4. VIVA TRAP: Can a patient with severe rheumatic mitral stenosis and pulmonary hypertension safely participate in competitive contact sports if they are currently asymptomatic?	NEVER. Patients with moderate-to-severe mitral stenosis or significant valvular lesions are strictly restricted from competitive and strenuous isometric sports due to the high risk of acute pulmonary edema and sudden decompensation.
5. VIVA TRAP: Is subclinical carditis detected exclusively via routine school screening echocardiography an indication for starting anti-inflammatory steroid therapy?	NO. Anti-inflammatory therapy (aspirin or corticosteroids) is not indicated for isolated subclinical carditis without clinical signs of inflammation or heart failure; management centers strictly on rigorous secondary antibiotic prophylaxis.
6. VIVA TRAP: Can pregnant adolescents with mechanical heart valves for severe RHD safely continue oral Warfarin throughout all trimesters of pregnancy without modification?	NEVER. Warfarin is teratogenic during the first trimester (embryopathy) and poses severe fetal hemorrhage risks near term; it must be managed via a specialized protocol bridging to low-molecular-weight heparin or unfractionated heparin during critical gestational windows.
7. VIVA TRAP: Are throat cultures mandatory and diagnostic for confirming rheumatic fever if they yield negative results during the acute arthritis presentation?	NO. By the time acute rheumatic fever clinical manifestations appear, the preceding streptococcal pharyngitis has often resolved, rendering throat cultures negative in up to 70-80% of cases; serology (ASO/Anti-DNase B) is required instead.
8. VIVA TRAP: Can a child who develops a severe neuropsychiatric presentation of Sydenham chorea be treated with standard high-dose systemic corticosteroids as the primary first-line immunomodulator?	NO. While corticosteroids can be used in severe cases, first-line medical management for chorea focuses on dopamine receptor blockers (like haloperidol) or antiepileptics (like valproate or carbamazepine) to control hyperkinesia safely.
9. VIVA TRAP: Is a normal erythrocyte sedimentation rate (ESR) sufficient to rule out the diagnosis of active acute rheumatic fever in a patient presenting with classic migratory polyarthritis?	NO. Although ESR is typically elevated, it can occasionally be normal or falsely depressed in patients with congestive heart failure or concurrent congestive hepatomegaly; furthermore, CRP remains the more reliable acute-phase reactant.
10. VIVA TRAP: Can intramuscular Benzathine Penicillin G be administered intravenously if rapid systemic absorption is urgently desired in severe rheumatic carditis?	NEVER. Benzathine Penicillin G is formulated specifically as an insoluble suspension for slow intramuscular depot absorption; intravenous administration can cause catastrophic cardiopulmonary arrest, severe neurovascular toxicity, and death.
11. VIVA TRAP: Should a child diagnosed with acute rheumatic carditis be placed on strict, prolonged absolute bed rest throughout the entire duration of hospitalization?	NO. Absolute bed rest is no longer recommended as it increases the risk of deep vein thrombosis and psychological distress; mobilization should be guided by the resolution of heart failure, fever, and tachycardia.
12. VIVA TRAP: Is echocardiographic screening of school children for latent rheumatic heart disease recommended as a mandatory universal public health screening tool globally?	NO. Universal screening is resource-intensive and controversial; current WHO guidelines recommend it only in regions with a high endemic burden of rheumatic fever where programmatic secondary prophylaxis infrastructure exists.
13. VIVA TRAP: Can oral non-steroidal anti-inflammatory drugs other than Aspirin (such as Ibuprofen) be routinely substituted for managing the arthritis and carditis of acute rheumatic fever?	NO. Aspirin is the classic time-tested salicylate specifically proven to suppress the systemic inflammation of acute rheumatic fever; other NSAIDs lack equivalent clinical trial data and guidelines backing for ARF carditis management.
14. VIVA TRAP: Can diagnostic criteria for Acute Rheumatic Fever be established using the Jones criteria with two minor manifestations and a documented past history of RHD without evidence of a recent GAS infection?	NO. Demonstrating antecedent Group A Streptococcal infection is an absolute mandatory prerequisite in the Jones criteria; lacking proof of prior streptococcal infection invalidates the diagnosis of primary ARF (except in pure chorea presentations where GAS may have cleared).
15. VIVA TRAP: Are rheumatic nodules painful and associated with localized acute inflammatory warmth on palpation over the extensor tendons?	NO. Rheumatic nodules are characteristically painless, hard, mobile, and non-tender subcutaneous swellings situated over bony prominences and extensor tendons, lacking local inflammatory signs.